[Thromboembolism risk of intravenous immunoglobulin therapy: Myth or reality?].
Marie
I
I
Lévesque
H
H
D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D007155:Immunologic Factors / Q000009:adverse effects*; D012307:Risk Factors; D013923:Thromboembolism / Q000276:immunology*
D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors